Skip to main content
Veterinary Medicines

Bupaq 0,3 mg/ml Injektionslösung für Hunde und Katzen

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Bupaq 0,3 mg/ml Injektionslösung für Hunde und Katzen
Buprenovet sine 0,3 mg/ml Injektionslösung für Hunde und Katzen
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Clear glass vials type II, coated bromobutyl rubber stopper type I, aluminium cap, packed in a cardboard box. Package size: Cardboard box with 10 vials of 2 ml
  • Clear glass vials type II, coated bromobutyl rubber stopper type I, aluminium cap, packed in a cardboard box. Package size: Cardboard box with 3 vials of 2 ml
  • Clear glass vials type II, coated bromobutyl rubber stopper type I, aluminium cap, packed in a cardboard box. Package size: Cardboard box with 4 vials of 2 ml
  • Clear glass vials type II, coated bromobutyl rubber stopper type I, aluminium cap, packed in a cardboard box. Package size: Cardboard box with 5 vials of 2 ml
  • Clear glass vials type II, coated bromobutyl rubber stopper type I, aluminium cap, packed in a cardboard box. Package size: Cardboard box with 6 vials of 2 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402559.00.00
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0008/002
Concerned member states:
  • Bulgaria
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Norway
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/07/2022
Download
German (PDF)
Published on: 3/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/01/2025